CH572745A5 - - Google Patents

Info

Publication number
CH572745A5
CH572745A5 CH793671A CH793671A CH572745A5 CH 572745 A5 CH572745 A5 CH 572745A5 CH 793671 A CH793671 A CH 793671A CH 793671 A CH793671 A CH 793671A CH 572745 A5 CH572745 A5 CH 572745A5
Authority
CH
Switzerland
Application number
CH793671A
Original Assignee
Statens Bakteriologiska Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Bakteriologiska Lab filed Critical Statens Bakteriologiska Lab
Publication of CH572745A5 publication Critical patent/CH572745A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH793671A 1970-06-02 1971-06-01 CH572745A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (en) 1970-06-02 1970-06-02

Publications (1)

Publication Number Publication Date
CH572745A5 true CH572745A5 (en) 1976-02-27

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
CH793671A CH572745A5 (en) 1970-06-02 1971-06-01

Country Status (8)

Country Link
AT (1) AT309678B (en)
CA (1) CA960964A (en)
CH (1) CH572745A5 (en)
DE (1) DE2127159C2 (en)
FR (1) FR2100716B1 (en)
GB (1) GB1344340A (en)
NL (1) NL177599C (en)
SE (1) SE348942B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952690A1 (en) * 1978-12-29 1980-07-03 Kureha Chemical Ind Co Ltd PHARMACEUTICAL PREPARATION

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (en) * 1974-06-14 1976-11-15 P G S Lindroos SUGGESTED TO SEPARATE GLOBIN IRON COMPOUNDS FROM A VETICAL CONTAINING BLOOD SUBSTANCES
DE2500076C3 (en) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Process for the production of intravenously tolerated gamma globulins
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (en) * 1978-09-19 1980-11-25 Immuno Ag METHOD FOR PRODUCING AN INTRAVENOUS ADMINISTRABLE ANTIBODY-CONTAINING IMMUNOGLOBULIN PREPARATE
WO2010082894A1 (en) * 2009-01-13 2010-07-22 Ge Healthcare Bio-Sciences Ab Precipitation of biomolecules with negatively charged polymers
SG176256A1 (en) 2009-05-27 2012-01-30 Baxter Int A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
IT1397061B1 (en) * 2009-12-28 2012-12-28 Kedrion Spa NEW PROCESS OF PURIFICATION ON INDUSTRIAL SCALE OF GAMMAGLOBULINE FROM HUMAN PLASMA FOR INDUSTRIAL USE.
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
AR087953A1 (en) 2011-08-26 2014-04-30 Baxter Int METHOD FOR REDUCING THE THROMBOEMBOLIC POTENTIAL OF A PLASMA DERIVED IMMUNOGLOBULIN COMPOSITION
TWI629283B (en) 2012-02-23 2018-07-11 巴克斯歐塔公司 Fraction i-iv-1 precipitation of immunoglobins from plasma
CN110343171A (en) 2012-02-29 2019-10-18 百深公司 Perineural IgG stimulates Remyelination
HUE046752T2 (en) 2013-02-26 2020-03-30 Baxalta GmbH Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
PT2994160T (en) 2013-05-06 2019-08-07 Baxalta Inc Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
WO2023170553A1 (en) 2022-03-07 2023-09-14 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (en) * 1962-01-03
BE713764A (en) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (en) * 1967-11-15 1969-10-10 Immuno Ag Process for the production of pure blood albumin from protein solutions containing hemopigments

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952690A1 (en) * 1978-12-29 1980-07-03 Kureha Chemical Ind Co Ltd PHARMACEUTICAL PREPARATION
US4401592A (en) 1978-12-29 1983-08-30 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity

Also Published As

Publication number Publication date
GB1344340A (en) 1974-01-23
FR2100716B1 (en) 1975-06-06
CA960964A (en) 1975-01-14
NL7107529A (en) 1971-12-06
FR2100716A1 (en) 1972-03-24
DE2127159A1 (en) 1971-12-09
NL177599C (en) 1985-10-16
DE2127159C2 (en) 1981-12-24
SE348942B (en) 1972-09-18
AT309678B (en) 1973-08-27
NL177599B (en) 1985-05-17

Similar Documents

Publication Publication Date Title
ATA96471A (en)
AU1146470A (en)
AU2044470A (en)
AU1473870A (en)
AU1326870A (en)
AU2085370A (en)
AU2017870A (en)
AU1833270A (en)
AU1716970A (en)
AU1517670A (en)
AU1336970A (en)
AU1591370A (en)
AU1064870A (en)
AU2144270A (en)
AU2131570A (en)
AU2130770A (en)
AU1277070A (en)
AU1328670A (en)
AU1247570A (en)
AU1343870A (en)
AU2130570A (en)
AU2119370A (en)
AU1235770A (en)
AU1581370A (en)
AU1189670A (en)

Legal Events

Date Code Title Description
PL Patent ceased